Figure 1.
Plk1 level is correlated with tumorigenicity in different prostate cell lines. (A) Immunoblotting of Plk1 in RWPE-1, LNCaP, C4–2 and PC3 cells. (B) RWPE-1, LNCaP, C4-2 and PC3 cells were treated with 20 nmol/L BI2536 for 24 hours and harvested.